{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:53:51Z","timestamp":1761555231506,"version":"build-2065373602"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,11]],"date-time":"2021-07-11T00:00:00Z","timestamp":1625961600000},"content-version":"am","delay-in-days":344,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.cct.2020.106078","type":"journal-article","created":{"date-parts":[[2020,7,4]],"date-time":"2020-07-04T11:19:17Z","timestamp":1593861557000},"page":"106078","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Virtual mind-body treatment for adolescents with neurofibromatosis: Study protocol for a single-blind randomized controlled trial"],"prefix":"10.1016","volume":"95","author":[{"given":"Mira","family":"Reichman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Riklin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Macklin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana-Maria","family":"Vranceanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cct.2020.106078_bb0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/ajmg.a.33139","article-title":"Birth incidence and prevalence of tumor-prone syndromes: estimates from a UK family genetic register service","volume":"152A","author":"Evans","year":"2010","journal-title":"Am. J. Med. Genet. A"},{"issue":"2","key":"10.1016\/j.cct.2020.106078_bb0010","first-page":"E47","article-title":"The Neurofibromatoses. Part 1: NF1","volume":"6","author":"Lu-Emerson","year":"2009","journal-title":"Rev. Neurol. Dis."},{"issue":"1","key":"10.1016\/j.cct.2020.106078_bb0015","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1212\/WNL.54.1.71","article-title":"Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas","volume":"54","author":"Antinheimo","year":"2000","journal-title":"Neurology."},{"issue":"3","key":"10.1016\/j.cct.2020.106078_bb0020","first-page":"E81","article-title":"The neurofibromatoses. Part 2: NF2 and schwannomatosis","volume":"6","author":"Lu-Emerson","year":"2009","journal-title":"Rev. Neurol. Dis."},{"key":"10.1016\/j.cct.2020.106078_bb0025","doi-asserted-by":"crossref","DOI":"10.1186\/1750-1172-7-75","article-title":"Growth dynamics of plexiform neurofibromas: a retrospective cohort study of 201 patients with neurofibromatosis 1","volume":"7","author":"Nguyen","year":"2012","journal-title":"Orphanet. J. Rare Dis."},{"issue":"2","key":"10.1016\/j.cct.2020.106078_bb0030","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s11060-015-1725-1","article-title":"Quality of life among children and adolescents with neurofibromatosis 1: a systematic review of the literature","volume":"122","author":"Vranceanu","year":"2015","journal-title":"J. Neuro-Oncol."},{"issue":"8","key":"10.1016\/j.cct.2020.106078_bb0035","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1017\/S0012162204000921","article-title":"Social skills of children with neurofibromatosis type 1","volume":"46","author":"Barton","year":"2004","journal-title":"Dev. Med. Child Neurol."},{"issue":"6","key":"10.1016\/j.cct.2020.106078_bb0040","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0022-3476(99)70296-9","article-title":"Social and emotional problems in children with neurofibromatosis type 1: evidence and proposed interventions","volume":"134","author":"Johnson","year":"1999","journal-title":"J. Pediatr."},{"issue":"3","key":"10.1016\/j.cct.2020.106078_bb0045","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/s10897-016-0036-9","article-title":"Knowledge and self-esteem of individuals with neurofibromatosis type 1 (NF1)","volume":"26","author":"Rosnau","year":"2017","journal-title":"J. Genet. Couns."},{"issue":"7","key":"10.1016\/j.cct.2020.106078_bb0050","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/jpepsy\/jsr124","article-title":"Social-emotional functioning of children and adolescents with neurofibromatosis type 1 and plexiform neurofibromas: relationships with cognitive, disease, and environmental variables","volume":"37","author":"Martin","year":"2012","journal-title":"J. Pediatr. Psychol."},{"key":"10.1016\/j.cct.2020.106078_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/975364","article-title":"Physical, cognitive, and psychosocial predictors of functional disability and health-related quality of life in adolescents with neurofibromatosis-1","volume":"2012","author":"Garwood","year":"2012","journal-title":"Pain Res. Treat."},{"issue":"4","key":"10.1016\/j.cct.2020.106078_bb0060","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1002\/ajmg.a.38640","article-title":"Challenges associated with parenting youth with neurofibromatosis: a qualitative investigation","volume":"176","author":"Pierre-Louis","year":"2018","journal-title":"Am. J. Med. Genet. A"},{"issue":"3","key":"10.1016\/j.cct.2020.106078_bb0065","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s11060-013-1195-2","article-title":"Quality of life among adult patients with neurofibromatosis 1, neurofibromatosis 2 and schwannomatosis: a systematic review of the literature","volume":"114","author":"Vranceanu","year":"2013","journal-title":"J. Neuro-Oncol."},{"issue":"2","key":"10.1016\/j.cct.2020.106078_bb0070","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11060-017-2720-5","article-title":"The impact of a mind-body program on multiple dimensions of resiliency among geographically diverse patients with neurofibromatosis","volume":"137","author":"Zale","year":"2018","journal-title":"J. Neuro-Oncol."},{"issue":"8","key":"10.1016\/j.cct.2020.106078_bb0075","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1212\/WNL.0000000000003005","article-title":"Mind-body therapy via videoconferencing in patients with neurofibromatosis: an RCT","volume":"87","author":"Vranceanu","year":"2016","journal-title":"Neurology."},{"issue":"10","key":"10.1016\/j.cct.2020.106078_bb0080","doi-asserted-by":"crossref","DOI":"10.2196\/11008","article-title":"Mind-body treatment for international English-speaking adults with neurofibromatosis via live videoconferencing: protocol for a single-blind randomized controlled trial","volume":"7","author":"Vranceanu","year":"2018","journal-title":"JMIR Res. Protoc."},{"issue":"1","key":"10.1016\/j.cct.2020.106078_bb0085","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s11060-014-1522-2","article-title":"The relaxation response resiliency program (3RP) in patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis: results from a pilot study","volume":"120","author":"Vranceanu","year":"2014","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.cct.2020.106078_bb0090","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.genhosppsych.2019.12.001","article-title":"Virtual mind-body treatment for geographically diverse youth with neurofibromatosis: a pilot randomized controlled trial","volume":"62","author":"Lester","year":"2020","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.cct.2020.106078_bb0095","doi-asserted-by":"crossref","DOI":"10.1007\/s11060-020-03441-8","article-title":"Improvement in resiliency factors among adolescents with neurofibromatosis who participate in a virtual mind-body group program","author":"Lester","year":"2020","journal-title":"J Neurooncol."},{"issue":"2","key":"10.1016\/j.cct.2020.106078_bb0100","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.psym.2012.09.001","article-title":"The development of a patient-centered program based on the relaxation response: the relaxation response resiliency program (3RP)","volume":"54","author":"Park","year":"2013","journal-title":"Psychosomatics."},{"issue":"2","key":"10.1016\/j.cct.2020.106078_bb0105","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s11205-005-0211-0","article-title":"Applicability of the WHOQOL-BREF on early adolescence","volume":"79","author":"Chen","year":"2006","journal-title":"Soc. Indic. Res."},{"issue":"3","key":"10.1016\/j.cct.2020.106078_bb0110","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S1054-139X(01)00333-0","article-title":"The patient health questionnaire for adolescents: validation of an instrument for the assessment of mental disorders among adolescent primary care patients","volume":"30","author":"Johnson","year":"2002","journal-title":"J. Adolesc. Health"},{"issue":"2","key":"10.1016\/j.cct.2020.106078_bb0115","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1023\/B:QURE.0000018486.91360.00","article-title":"The World Health Organization\u2019s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial a report from the WHOQOL group","volume":"13","author":"Skevington","year":"2004","journal-title":"Qual. Life Res."},{"issue":"3","key":"10.1016\/j.cct.2020.106078_bb0120","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/08870446.2013.845668","article-title":"How appropriate is the WHOQOL-BREF for assessing the quality of life of adolescents?","volume":"29","author":"Skevington","year":"2014","journal-title":"Psychol. Health"},{"issue":"9","key":"10.1016\/j.cct.2020.106078_bb0125","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"issue":"10","key":"10.1016\/j.cct.2020.106078_bb0130","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch. Intern. Med."},{"issue":"4","key":"10.1016\/j.cct.2020.106078_bb0135","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/104012371702900404","article-title":"The generalized anxiety disorder 7-item scale in adolescents with generalized anxiety disorder: signal detection and validation","volume":"29","author":"Mossman","year":"2017","journal-title":"Ann. Clin. Psychiatry Am. Acad. Clin. Psychiatr. AACP."},{"issue":"2","key":"10.1016\/j.cct.2020.106078_bb0140","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","article-title":"Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale","volume":"94","author":"Farrar","year":"2001","journal-title":"PAIN."},{"issue":"3","key":"10.1016\/j.cct.2020.106078_bb0145","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/AJP.0000000000000104","article-title":"Agreement between verbal and electronic versions of the numerical rating scale (NRS-11) when used to assess pain intensity in adolescents","volume":"31","author":"Castarlenas","year":"2015","journal-title":"Clin. J. Pain"},{"issue":"3","key":"10.1016\/j.cct.2020.106078_bb0150","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pain.2009.03.002","article-title":"Three new datasets supporting use of the Numerical Rating Scale (NRS-11) for children\u2019s self-reports of pain intensity","volume":"143","author":"von Baeyer","year":"2009","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.cct.2020.106078_bb0155","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/pme.12620","article-title":"Development and validation of the english pain interference index and pain interference index- parent report","volume":"16","author":"Martin","year":"2015","journal-title":"Pain Med."},{"issue":"3","key":"10.1016\/j.cct.2020.106078_bb0160","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1037\/a0022819","article-title":"Assessing mindfulness in children and adolescents: development and validation of the child and adolescent mindfulness measure (CAMM)","volume":"23","author":"Greco","year":"2011","journal-title":"Psychol. Assess."},{"issue":"1","key":"10.1016\/j.cct.2020.106078_bb0165","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1037\/0022-3514.82.1.112","article-title":"The grateful disposition: a conceptual and empirical topography","volume":"82","author":"Mccullough","year":"2002","journal-title":"J. Pers. Soc. Psychol."},{"issue":"1","key":"10.1016\/j.cct.2020.106078_bb0170","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1037\/0022-3514.44.1.113","article-title":"Measuring individual differences in empathy: evidence for a multidimensional approach","volume":"44","author":"Davis","year":"1983","journal-title":"J. Pers. Soc. Psychol."},{"author":"Carver","key":"10.1016\/j.cct.2020.106078_bb0175"},{"issue":"6","key":"10.1016\/j.cct.2020.106078_bb0180","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/0277-9536(91)90150-B","article-title":"The MOS social support survey","volume":"32","author":"Sherbourne","year":"1991","journal-title":"Soc. Sci. Med."},{"issue":"2","key":"10.1016\/j.cct.2020.106078_bb0185","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1037\/a0031034","article-title":"Mediation analysis allowing for exposure-mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros","volume":"18","author":"Valeri","year":"2013","journal-title":"Psychol. Methods"},{"issue":"6","key":"10.1016\/j.cct.2020.106078_bb0190","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1037\/0022-3514.51.6.1173","article-title":"The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations","volume":"51","author":"Baron","year":"1986","journal-title":"J. Pers. Soc. Psychol."},{"issue":"10","key":"10.1016\/j.cct.2020.106078_bb0195","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1001\/archpsyc.59.10.877","article-title":"Mediators and moderators of treatment effects in randomized clinical trials","volume":"59","author":"Kraemer","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2","key":"10.1016\/j.cct.2020.106078_bb0200","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J. Biomed. Inform."}],"container-title":["Contemporary Clinical Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714420301567?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551714420301567?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:50:43Z","timestamp":1761555043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551714420301567"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":40,"alternative-id":["S1551714420301567"],"URL":"https:\/\/doi.org\/10.1016\/j.cct.2020.106078","relation":{},"ISSN":["1551-7144"],"issn-type":[{"type":"print","value":"1551-7144"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Virtual mind-body treatment for adolescents with neurofibromatosis: Study protocol for a single-blind randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cct.2020.106078","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106078"}}